Metsystem

Denmark Founded: 2023 • Age: 3 yrs
Offers advanced drug screens for predicting cancer metastasis and personalized treatments.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About Metsystem

Metsystem is a company based in Denmark founded in 2023. It operates as a B2B and D2C. Metsystem offers products and services including METscreen. Metsystem operates in a competitive market with competitors including Sable Bio, Mensura Health, Intero Biosystems, Pharmacovigilance and Mimi-Q, among others.

  • Headquarter Denmark
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Metsystem

Metsystem offers a comprehensive portfolio of products and services, including METscreen.

Product name locked
Category locked
Primary

Platform predicts cancer metastasis and identifies personalized treatments effectively.

Funding Insights of Metsystem

Premium access

Detailed funding history for Metsystem

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Metsystem

Investments
Premium access

Investment portfolio details for Metsystem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Metsystem

Premium access

Detailed financials for Metsystem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Metsystem Comparisons

Metsystem Primary company
Description
Offers advanced drug screens for predicting cancer metastasi...
Location
Denmark
Founded Year
2023
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Metsystem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Metsystem

Metsystem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sable Bio, Mensura Health, Intero Biosystems, Pharmacovigilance and Mimi-Q, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug safety risks are predicted via AI in pharmaceuticals.
Locked Locked Locked
Mensura Health is focused on epilepsy patient management solutions.
Locked Locked Locked
Develops human organoids for preclinical drug testing and research applications.
Locked Locked Locked
Delivers data analytics dashboards for drug safety professionals.
Locked Locked Locked
Develops software for virtual patient modeling, clinical trial simulations, and drug response prediction.
Premium access

Detailed competitors of Metsystem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Metsystem

Premium access

Complete news archive for Metsystem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Metsystem

Metsystem was founded in 2023.

Metsystem is headquartered in Denmark.

METSYSTEM develops innovative platforms like METscreen to predict cancer spread using metastasis-targeting technologies and patient-derived organoids. It analyzes intratumor heterogeneity to deliver actionable insights for doctors, enabling tailored treatment decisions. Based in Copenhagen, Denmark, the company collaborates with patients and researchers to advance precision oncology across various cancers, focusing on preventative and effective therapies.

Metsystem's top competitors include Sable Bio, Mensura Health and Intero Biosystems.

Metsystem offers METscreen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available